NELFA and cardiac hypertrophy: MiR-133 controls cardiomyocyte hypertrophy by acting on different target genes, including Cdc42 (a signal transduction kinase), Nelf-A/WHSC2 (a nuclear factor related to heart development), and RhoA (a GDP/GTP exchange protein that regulates cardiac hypertrophy) (38).